Oragenics Inc. (OGEN)
Oragenics Signs Letter of Intent to LicenseCardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Oragenics Signs Letter of Intent to LicenseCardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial